TuHURA Biosciences, Inc. (HURA)

TuHURA Biosciences Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
Cash & Equivalents	2.7	12.66	3.67	14.25
Cash & Short-Term Investments	2.7	12.66	3.67	14.25
Cash Growth	-86.23%	245.35%	-74.28%	-
Other Receivables	0.42	0.64	0.33	-
Receivables	0.42	0.64	0.33	0.1
Other Current Assets	0.39	6.31	0.16	0.39
Total Current Assets	3.5	19.61	4.16	14.74
Property, Plant & Equipment	0.38	0.32	0.2	0.42
Other Long-Term Assets	-	0.03	-	0.03
Total Assets	25.7	19.97	4.36	15.2
Accounts Payable	4.13	3.15	1.87	1.92
Accrued Expenses	1.31	2.02	1.57	0.84
Current Portion of Leases	0.13	0.16	0.02	0.12
Other Current Liabilities	2.78	-	0.14	-
Total Current Liabilities	8.83	5.33	3.6	2.87
Long-Term Debt	-	-	2.32	-
Long-Term Leases	0.08	0.04	-	0.02
Total Liabilities	8.92	5.37	5.92	2.89
Common Stock	0.05	0.04	0.01	0
Additional Paid-In Capital	150.87	125.4	86.89	71.45
Retained Earnings	-134.42	-111.12	-88.47	-59.16
Total Common Equity	16.5	14.32	-1.58	12.3
Shareholders' Equity	16.78	14.59	-1.56	12.3
Total Liabilities & Equity	25.7	19.97	4.36	15.2
Total Debt	0.71	0.2	2.34	0.14
Net Cash (Debt)	1.99	12.45	1.32	14.11
Net Cash Growth	-	843.49%	-90.65%	-
Net Cash Per Share	0.05	0.67	0.11	-
Filing Date Shares Outstanding	51.26	43.68	68.01	-
Total Common Shares Outstanding	51.25	42.32	68.01	-
Working Capital	-5.33	14.28	0.56	11.87
Book Value Per Share	0.32	0.34	-0.02	-
Tangible Book Value	2.95	14.32	-1.58	12.3
Tangible Book Value Per Share	0.06	0.34	-0.02	-
Machinery	1.81	1.59	1.54	1.5
Leasehold Improvements	0.54	0.54	0.54	0.54

Updated Nov 14, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q